Andreas Larentzakis Selected Research

Resuscitation

1/2017

Association Between Ratio of Fresh Frozen Plasma to Red Blood Cells During Massive Transfusion and Survival Among Patients Without Traumatic Injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas Larentzakis Research Topics

Disease

7	Wounds and Injuries (Trauma) 07/2020 - 01/2014
5	Hemorrhage 06/2017 - 01/2013
3	Infections 01/2022 - 06/2008
3	Surgical Wound Infection 12/2014 - 07/2013
2	Necrosis 06/2017 - 03/2011
2	Exsanguination 03/2015 - 12/2014
1	Appendicitis 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	COVID-19 10/2021
1	Type 2 Diabetes Mellitus (MODY) 10/2021
1	Anaphylaxis (Anaphylactic Shock) 07/2021
1	Adenocarcinoma 04/2021
1	Peritoneal Neoplasms 04/2021
1	Urachal cancer 01/2021
1	Abdominal Hernia (Abdominal Hernias) 01/2021
1	Alcoholism (Alcohol Abuse) 07/2020
1	Delirium 07/2020
1	Craniocerebral Trauma (Head Injury) 07/2020
1	Neoplasm Metastasis (Metastasis) 12/2019
1	Edema (Dropsy) 06/2017
1	Lacerations 11/2015
1	Traumatic Amputation (Traumatic Amputations) 03/2015
1	Soft Tissue Injuries (Soft Tissue Injury) 03/2015
1	Vascular System Injuries 03/2015
1	Sepsis (Septicemia) 10/2014
1	Esophageal Neoplasms (Esophageal Cancer) 04/2014
1	Pancreatic Fistula (Pancreatic Fistulas) 07/2013
1	Pneumonia (Pneumonitis) 07/2013
1	Myxoma (Myxomas) 05/2011
1	Acidosis 03/2011
1	Ischemia 03/2011
1	Intra-Abdominal Hypertension 11/2009
1	Heart Failure 05/2009
1	Hemorrhagic Shock 09/2008
1	Septic Shock (Toxic Shock Syndrome) 06/2008
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/2008
1	Neoplasms (Cancer) 01/2008

Drug/Important Bio-Agent (IBA)

3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 06/2008
2	Hemostatics (Antihemorrhagics)IBA 01/2017 - 02/2015
2	polyurethane foamIBA 07/2015 - 02/2015
1	Insulin (Novolin)FDA Link 10/2021
1	Coloring Agents (Dyes)IBA 07/2021
1	Biological ProductsIBA 01/2021
1	Minocycline (Cyclops)FDA LinkGeneric 01/2021
1	BenzodiazepinesIBA 07/2020
1	Phenobarbital (Luminal)FDA Link 07/2020
1	catch-relaxing peptide (Mytilus)IBA 12/2019
1	CollagenIBA 06/2017
1	Indicators and Reagents (Reagents)IBA 11/2015
1	SaltsIBA 01/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2013
1	Pyruvic Acid (Pyruvate)IBA 01/2013
1	Hemoglobins (Hemoglobin)IBA 01/2013
1	Tumor Biomarkers (Tumor Markers)IBA 05/2011
1	AntigensIBA 05/2011
1	CarbohydratesIBA 05/2011
1	ProcalcitoninIBA 03/2011
1	Simendan (Levosimendan)IBA 05/2009
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 09/2008
1	Colistin (Coly-Mycin)FDA Link 06/2008
1	AminoglycosidesIBA 06/2008
1	Pharmaceutical PreparationsIBA 06/2008
1	Etoposide (VP 16)FDA LinkGeneric 01/2008

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 01/2022 - 01/2008
3	Therapeutics 04/2021 - 01/2008
2	Hyperthermic Intraperitoneal Chemotherapy 04/2021 - 12/2019
2	Tourniquets 03/2015 - 12/2014
1	Mammaplasty (Breast Reconstruction) 01/2022
1	Mastectomy (Mammectomy) 01/2022
1	Bariatric Surgery 10/2021
1	Cytoreduction Surgical Procedures 04/2021
1	Resuscitation 01/2017
1	Punctures 11/2015
1	Length of Stay 12/2014
1	Mechanical Ventilators (Ventilator) 10/2014
1	Neoadjuvant Therapy 04/2014
1	Esophagectomy 04/2014
1	Pancreaticojejunostomy 07/2013
1	Laparotomy 11/2009
1	Critical Care (Surgical Intensive Care) 06/2008
1	Central Venous Catheters 06/2008